Legal Representation
Attorney
Peter T. Wakiyama
USPTO Deadlines
Application History
14 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Oct 23, 2017 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Oct 23, 2017 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
Mar 27, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 27, 2017 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Mar 27, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 15, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 15, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Mar 15, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Sep 15, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 15, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Sep 15, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Sep 8, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 1, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
May 27, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Sequencing and analysis of genetic material from patients, consulting and research services in the nature of analysis and interpretation of patient genomic data and molecular tests, and providing reports containing the results thereof, all for medical treatment purposes
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"MOLECULAR HEALTH"